- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 247
Douyu looks to channel $500m in IPO
Tencent owns more than 40% of the China-based live game streaming platform, which has chosen New York for its initial public offering.
Apr 23, 2019Hookipa nets $84m initial public offering
Gilead Sciences, Boehringer Ingelheim and Takeda all recorded exits as immunotherapy developer Hookipa went public, floating at the bottom of its range.
Apr 23, 2019Life360 to embrace $104m IPO
Life360, backed by ADT, BMW and Duchossois Group, plans to go public in Australia next month after pricing its shares for a company valuation of $494m.
Apr 23, 2019Netcore acquires Quinto.ai after pivot
Rebel Foods has exited chatbot developer Quinto Technologies in an acquisition of undisclosed size by Netcore Solutions.
Apr 22, 2019Reali locks in Lenda acquisition
Reali will onboard the company's technology to create an online mortgage application platform following the acquisition, which allowed CreditEase Fintech Investment Fund to exit.
Apr 19, 2019Twitter draws up Highly acquisition
Bloomberg Beta has exited online text highlighting tool developer Highly in an acquisition of undisclosed size by Twitter.
Apr 19, 2019Pinterest hits NYSE in $1.4bn IPO
Qualcomm-backed visual social media platform Pinterest floated above its range in an offering that will give it a market cap near $13bn.
Apr 18, 2019Zoom crashes into public markets with $751m
Zoom is floating above its range in an IPO in which Qualcomm will make an immediate $30.6m return, while Salesforce is buying $100m of shares through a private placement.
Apr 18, 2019Salesforce locates MapAnything for acquisition deal
Salesforce has agreed to buy the location services provider in a deal that will hand exits to fellow corporate investors ServiceNow and General Motors.
Apr 18, 2019Gyroscope enters Orbit for merger
Gyroscope Therapeutics, spun out of Cambridge and Syncona, has merged with Orbit Biomedical to form a fully-integrated retinal gene therapy developer.
Apr 18, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


